Cart
sales@molnova.com
PR-825
CAS No. 935888-08-7
PR-825( PR825 | PR 825 )
Catalog No. M16696 CAS No. 935888-08-7
A potent, specific immunoproteasome β5 subunit inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1233 | In Stock |
|
| 50MG | 2502 | In Stock |
|
| 100MG | 3330 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePR-825
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, specific immunoproteasome β5 subunit inhibitor.
-
DescriptionA potent, specific immunoproteasome β5 subunit inhibitor.
-
In Vitro——
-
In Vivo——
-
SynonymsPR825 | PR 825
-
PathwayProteasome/Ubiquitin
-
TargetProteasome
-
RecptorProteasome
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number935888-08-7
-
Formula Weight482.534
-
Molecular FormulaC22H34N4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameN-((S)-3-methoxy-1-(((S)-3-methoxy-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)-5-methylisoxazole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MG-101
A potent inhibitor of cysteine proteases including calpain I (Ki= 190 nM), calpain II (Ki= 220 nM), cathepsin B (Ki= 150 nM) and cathepsin L (Ki= 500 pM).
-
PR-924
A potent, specific immunoproteasome LMP7 subunit inhibitor with IC50 of 25 nM.
-
Oprozomib
Oprozomib (ONX-0912;PR-047) is a potent, orally bioavailable proteasome inhibitor that inhibits chymotrypsin-like (CT-L) activity of 20S proteasome β5/LMP7 with IC50 of 36/82 nM.
